PFKFB3 and amyotrophic lateral sclerosis: Because PFKFB3 is known to be a positive regulator of glycolysis, this finding supports a downregulation of glucose metabolism in ALS and is consistent with the results obtained in PET and proteomic studies [23,38,39].